Related Experiment Video
Updated: Jul 19, 2026
09:15
Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore
Published on: January 21, 2020
Protection from ischemic cell death by the induction of cytoglobin
J I Stagner1, S N Parthasarathy, K Wyler
1Research Service, Department of Veterans Affairs Medical Center, 800 Zorn Avenue, Louisville, KY 40206, USA.
Transplantation Proceedings
|November 22, 2005
Summary
Cytoglobin gene therapy may improve islet transplantation success by protecting beta-cells from death and reducing immune rejection. This could enhance survival and function of transplanted islets for diabetes treatment.
Area of Science:
- Endocrinology and Metabolism
- Cell Biology
- Transplantation Immunology
Background:
- Islet transplantation is a potential diabetes treatment, but beta-cell loss and graft failure remain significant challenges.
- Current research focuses on reducing immunosuppressant toxicity and improving graft vascularization.
- Cytoglobin, an oxygen-binding protein in beta-cells, is inducible by hypoxia and may protect against cell death.
Purpose of the Study:
- To investigate the potential of cytoglobin induction and overexpression to improve survival and function of transplanted islets.
- To determine if cytoglobin protects islets from ischemic cell death and immunorejection.
Main Methods:
- Lewis rat islets and MIN6 cells were transfected with the cytoglobin gene.
- Transfected and control cells/islets were exposed to varying oxygen concentrations (20% and 1%).
- Transfected islets were transplanted into streptozotocin-induced diabetic Lewis rats, with fasting blood glucose monitored.
Main Results:
- Cytoglobin-transfected islets maintained insulin secretion under low oxygen conditions, unlike controls.
- Cytoglobin overexpression reduced central islet necrosis in tissue culture.
- Transplanted cytoglobin-expressing islets showed delayed immunorejection (14 days vs. 5 days for controls).
Conclusions:
- Cytoglobin transfection enhances islet cell survival and function under hypoxic stress.
- Cytoglobin overexpression can mitigate ischemic damage and delay immune rejection of transplanted islets.
- Cytoglobin induction represents a promising strategy to improve islet transplantation outcomes for diabetes.
Related Concept Videos
01:30Overview of Cell Death
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:00Cellular Injury I: Introduction
Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
01:11Cellular Injury IlI: Cellular Death
Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...
01:16Cellular Injury IV: Necrosis
Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:21Cytotoxic Edema: Pathophysiology
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...